The Impact of Vaccinations Against Respiratory Infections on the Prognosis in Heart Failure Patients
- PMID: 39771983
- PMCID: PMC11679989
- DOI: 10.3390/vaccines12121321
The Impact of Vaccinations Against Respiratory Infections on the Prognosis in Heart Failure Patients
Abstract
Heart failure (HF) affects 64 million people worldwide and is one of the most prevalent causes of hospitalization in adults. Infection is believed to be one of the potential triggers that may facilitate HF decompensation and the need for hospitalization. Therefore, it seems crucial to safeguard against such a situation. Vaccinations seem to be a very reasonable option. However, this remains an underutilized solution among HF patients. This review investigates the impact of available vaccinations, including influenza, COVID-19, pneumococcal, and RSV, on prognosis in specific HF populations only, as there are pathophysiological reasons to believe that this population of patients may benefit the most from the intervention. It will provide information about the safety profile of these vaccines and summarize the available evidence on their impact on hard clinical outcomes. In summary, this article will discuss the impact of preventive vaccinations against seasonal infections in the HF population.
Keywords: COVID-19 vaccination; RSV vaccination; cardiovascular diseases; heart failure; influenza vaccination; pneumococcal vaccination.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Vaccination for Respiratory Infections in Patients with Heart Failure.J Clin Med. 2021 Sep 22;10(19):4311. doi: 10.3390/jcm10194311. J Clin Med. 2021. PMID: 34640328 Free PMC article. Review.
-
Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions.JACC Heart Fail. 2017 Mar;5(3):194-203. doi: 10.1016/j.jchf.2016.12.007. Epub 2017 Feb 1. JACC Heart Fail. 2017. PMID: 28161238 Free PMC article. Review.
-
Influenza and pneumococcal vaccination in heart failure: a little applied recommendation.Arq Bras Cardiol. 2011 Mar;96(3):240-5. doi: 10.1590/s0066-782x2011005000010. Epub 2011 Jan 21. Arq Bras Cardiol. 2011. PMID: 21271169 English, Portuguese, Spanish.
-
Adult vaccinations against respiratory infections.Expert Rev Anti Infect Ther. 2025 Feb-Apr;23(2-4):135-147. doi: 10.1080/14787210.2025.2457464. Epub 2025 Jan 31. Expert Rev Anti Infect Ther. 2025. PMID: 39849822 Review.
-
The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure.Vaccine. 2024 Apr 30;42(12):2937-2940. doi: 10.1016/j.vaccine.2024.03.060. Epub 2024 Mar 25. Vaccine. 2024. PMID: 38531725
References
-
- Salah H.M., Minhas A.M.K., Khan M.S., Khan S.U., Ambrosy A.P., Blumer V., Vaduganathan M., Greene S.J., Pandey A., Fudim M. Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018. ESC Heart Fail. 2022;9:947–952. doi: 10.1002/ehf2.13823. - DOI - PMC - PubMed
-
- Chen S., Huang Z., Liang Y., Zhao X., Aobuliksimu X., Wang B., He Y., Kang Y., Huang H., Li Q., et al. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort. ESC Heart Fail. 2022;9:2336–2347. doi: 10.1002/ehf2.13921. - DOI - PMC - PubMed
-
- Zymliński R., Sokolski M., Biegus J., Siwołowski P., Nawrocka-Millward S., Sokolska J.M., Dudkowiak M., Marciniak D., Todd J., Jankowska E.A., et al. Multi-organ dysfunction/injury on admission identifies acute heart failure patients at high risk of poor outcome. Eur. J. Heart Fail. 2018;21:744–750. doi: 10.1002/ejhf.1378. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous